According to iHealthcareAnalyst, Inc. Major Therapeutic Applications for Chronic Ailments to Drive Stem Cells Market to USD 25.8 Billion by 2020

Maryland Heights, MO, July 29, 2016 --(PR.com)-- The global stem cells market is estimated to reach USD 25.8 Billion in 2020, growing at a CAGR of 14.7% from 2016 to 2020, according to a new market research report Stem Cells Market – Global Therapeutic Products, Technologies and Applications Analysis and Forecast 2013-2020, published by iHealthcareAnalyst, Inc.

Visit the Stem Cells Market – Global Therapeutic Products, Technologies and Applications Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/stem-cells-market/

Stem cell-based therapies, also known as cell replacement therapies or regenerative medicine, provide the means to cure a host of diseases and disorders. There are various types of stem cells (adult stem cells, human embryonic stem cells, induced pluripotent stem cells, rat neural stem cells) available as therapeutic products in different applications (cardiology, diabetes, hematology, neurology, oncology, and orthopedics) diseases and disorders). The global stem cells market report estimates the market size (Revenue USD million - 2013 to 2020) and composition of this market and also forecasts growth trends (CAGR% - 2016 to 2020). It also covers the major companies operating in the market and provides detailed market analysis of the different stem cell technologies such as stem cells isolation, culture, cryopreservation, IVF, etc. available in the global market.

The global stem cells market is segmented as:
1. Product/Stem Cell Type
1.1. Adult/Somatic Stem Cells
1.2. Human Embryonic Stem Cells
1.3. Induced Pluripotent Stem Cells
1.4. Rat Neural Stem Cells
1.5. Other Stem Cells

2. Technology
2.1. Cryopreservation
2.2. Culture
2.3. Expansion and Sub-culture
2.4. In Vitro Fertilization (IVF)
2.5. Isolation

3. Application
3.1. Cardiovascular
3.2. Diabetes
3.3. Hematology
3.4. Incontinence
3.5. Liver Disorders
3.6. Myocardial infarction
3.7. Neurology
3.8. Oncology
3.9. Orthopedics
3.10. Spinal cord injuries
3.11. Wound care
3.12. Others

4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World

5. Company Profiles
5.1. Advanced Cell Technology
5.2. Angel Biotechnology
5.3. Bioheart
5.4. Biotime Inc.
5.5. Brainstorm Cell Therapeutics
5.6. California Stem Cell Inc.
5.7. Celgene Corporation Inc.
5.8. Cellartis AB
5.9. Cellular Engineering Technologies
5.10. Cytori Therapeutics Inc.
5.11. Osiris Therapeutics
5.12. Stem Cell Technologies Inc.

About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com